Cultivated

Cultivated Daily is the must-read, 5-minute daily newsletter for cannabis industry and policy professionals.

Connect

International updates from 🇨🇦 & 🇩🇪

One more day to catch Cultivated Live

a day ago

Guns and cannabis in the US - not so fast

Join us for Day 2 from Planet 13 in Las Vegas

2 days ago

New York cannabis settlement may open things up

Jay Rosenthal3 days ago

NH's adult-use prospects on hold

Cultivated Live starts streaming tomorrow from Las Vegas

4 days ago

NY's approach to cannabis - innovative (but slow)

5 days ago

Ohio's Senate President doesn’t trust voters on cannabis and abortion

It's our last Cultivated Daily until Monday

10 days ago

Cannabis workplace safety takes center stage in Massachusetts and beyond

How a worker's death may impact the growing industry

11 days ago

🤝 Welcome to Cultivated Daily

We’re building the one-stop, daily cannabis industry newsletter

12 days ago

Why Biden should legalize it, according to political science

Plus, it's cannabis earnings season, a new survey on weed use in America, and more.

16 days ago

What Ohio's landslide win for legalization tells us about cannabis politics

Plus, a troubling new study on cannabis and heart health, BAT invests in Organigram, and more.

23 days ago

The lawyer behind the suit to keep the federal government out of cannabis answers: Why now?

Plus, New York holds a marathon hearing on cannabis, and more.

a month ago

Rescheduling cannabis without banking reform risks 'supercharging' the biggest companies

Today's Cultivated is an op-ed from the Parabola Center's Shaleen Title and Bruce Barcott.

a month ago

Curaleaf lays off another round of employees

Plus, former DEA administrators say cannabis should remain a Schedule I drug, and more.

a month ago

South Africa wants to become the world's next cannabis tourism hotspot — but the government is standing in the way

Today's Sunday Read is a dispatch from South Africa's budding cannabis tourism industry by writer Ray Mwareya.

a month ago

How are cannabis companies preparing for the DEA's decision on rescheduling?

Regulatory change is a hot topic in the cannabis industry right now. A guest post from journalist Andrew Ward shows how businesses are prepping.

a month ago

Trulieve's recent legal spat highlights the trouble with cannabis social equity programs

Plus, Canada's legalization experiment five years in.

a month ago

The cannabis hype cycle is over. That's a good thing.

Plus, US cannabis companies march toward the TSX, and much more.

2 months ago

BREAKING: The SAFE(R) Act clears a key hurdle for a full vote

The SAFE(R) Banking Act passed the powerful Senate Banking Committee 14-9 this morning.

2 months ago

The drumbeat for the SAFE(R) Act continues

Maybe the tenth (?) time's a charm. That, and much more.

2 months ago

Cannabis legalization is coming. Sorta.

It's not actual legalization, but it's kinda close. Bear with me.

2 months ago

What are the pros and cons of moving cannabis to Schedule III?

Today, guest writer Andrew Ward helps you answer some burning questions.

3 months ago

There's an elemental struggle for the future of New York's cannabis market

Brace yourselves for an essay about capitalism, fairness, and cannabis.

3 months ago

Rescheduling cannabis probably won't change as much as you think

A potential move to Schedule III means less taxes for cannabis companies. The rest we're not so sure about. That, and more.

3 months ago

BREAKING: The HHS is calling for marijuana to be rescheduled

The U.S. Department of Health and Human Services (HHS) is recommending that cannabis be moved from Schedule I to Schedule III.

3 months ago

5 interesting things in the world of cannabis this week

It's a late August Hump Day. Take a breath, read some great stories.

3 months ago